Adaptive Biotechnologies to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Adaptive Biotechnologies (Nasdaq: ADPT), a commercial stage biotechnology company, has announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference in New York, NY. The company's management will take part in a fireside chat on Friday, September 6th at 9:20 a.m. Pacific Time / 12:20 p.m. Eastern Time.
Adaptive Biotechnologies focuses on translating the genetics of the adaptive immune system into clinical products for disease diagnosis and treatment. Interested parties can access a live and archived webcast of the presentation through the 'Investors' section of the company's website at www.adaptivebiotech.com.
Adaptive Biotechnologies (Nasdaq: ADPT), un'azienda biotecnologica in fase commerciale, ha annunciato la sua partecipazione alla 22ª Conferenza Annuale Globale sulla Salute di Morgan Stanley a New York, NY. La direzione dell'azienda parteciperà a una chiacchierata informale venerdì 6 settembre alle 9:20 ora del Pacifico / 12:20 ora dell'Est.
Adaptive Biotechnologies si concentra sulla traduzione della genetica del sistema immunitario adattivo in prodotti clinici per la diagnosi e il trattamento delle malattie. Le parti interessate possono accedere a una trasmissione web dal vivo e registrata della presentazione attraverso la sezione 'Investitori' del sito web dell'azienda all'indirizzo www.adaptivebiotech.com.
Adaptive Biotechnologies (Nasdaq: ADPT), una empresa biotecnológica en fase comercial, ha anunciado su participación en la 22ª Conferencia Anual Global de Atención Médica de Morgan Stanley en Nueva York, NY. La dirección de la empresa participará en una charla informal el viernes 6 de septiembre a las 9:20 a.m. hora del Pacífico / 12:20 p.m. hora del Este.
Adaptive Biotechnologies se enfoca en traducir la genética del sistema inmunológico adaptativo en productos clínicos para el diagnóstico y tratamiento de enfermedades. Las partes interesadas pueden acceder a una transmisión en vivo y grabada de la presentación a través de la sección 'Inversores' en el sitio web de la empresa en www.adaptivebiotech.com.
Adaptive Biotechnologies (Nasdaq: ADPT), 상업 단계의 생명공학 회사가 모건 스탠리 제22회 연례 글로벌 헬스케어 컨퍼런스에 뉴욕, NY에서 참여한다고 발표했습니다. 회사 경영진은 9월 6일 금요일 오전 9:20 태평양 시간/오후 12:20 동부 시간에 진행되는 담화에 참석할 예정입니다.
Adaptive Biotechnologies는 적응 면역 시스템의 유전학을 질병 진단 및 치료를 위한 임상 제품으로 전환하는 데 초점을 맞추고 있습니다. 관심이 있는 분들은 회사 웹사이트 '투자자' 섹션을 통해 발표의 생중계 및 녹화된 웹캐스트에 접근할 수 있습니다: www.adaptivebiotech.com.
Adaptive Biotechnologies (Nasdaq: ADPT), une entreprise de biotechnologie en phase commerciale, a annoncé sa participation à la 22e Conférence Annuelle Mondiale sur la Santé de Morgan Stanley à New York, NY. La direction de l'entreprise participera à une discussion informelle le vendredi 6 septembre à 9h20 heure du Pacifique / 12h20 heure de l'Est.
Adaptive Biotechnologies se concentre sur la traduction de la génétique du système immunitaire adaptatif en produits cliniques pour le diagnostic et le traitement des maladies. Les parties intéressées peuvent accéder à un webinaire en direct et à une archive de la présentation à travers la section 'Investisseurs' du site web de l'entreprise à l'adresse www.adaptivebiotech.com.
Adaptive Biotechnologies (Nasdaq: ADPT), ein Handelsunternehmen im Bereich Biotechnologie, hat seine Teilnahme an der 22. jährlichen globalen Gesundheitskonferenz von Morgan Stanley in New York, NY, bekannt gegeben. Das Management des Unternehmens wird an einem informellen Gespräch am Freitag, den 6. September um 9:20 Uhr Pazifischer Zeit / 12:20 Uhr Östlicher Zeit teilnehmen.
Adaptive Biotechnologies konzentriert sich darauf, die Genetik des adaptiven Immunsystems in klinische Produkte zur Diagnose und Behandlung von Krankheiten zu übersetzen. Interessierte Parteien können über den Abschnitt 'Investoren' der Unternehmenswebsite einen Live-Stream und eine Aufzeichnung der Präsentation abrufen unter www.adaptivebiotech.com.
- None.
- None.
SEATTLE, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming Morgan Stanley 22nd Annual Global Healthcare Conference in New York, NY.
Adaptive Biotechnologies’ management is scheduled to participate in a fireside chat on Friday, September 6th at 9:20 a.m. Pacific Time / 12:20 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.adaptivebiotech.com.
About Adaptive Biotechnologies
Adaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature’s most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed. We apply our platform to partner with biopharmaceutical companies, inform drug development, and develop clinical diagnostics across our two business areas: Minimal Residual Disease (MRD) and Immune Medicine. Our commercial products and clinical pipeline enable the diagnosis, monitoring, and treatment of diseases such as cancer, autoimmune disorders, and infectious diseases. Our goal is to develop and commercialize immune-driven clinical products tailored to each individual patient.
ADAPTIVE INVESTORS
Karina Calzadilla, Vice President, Investor Relations
201-396-1687
investors@adaptivebiotech.com
ADAPTIVE MEDIA
Erica Jones, Associate Director, Corporate Communications
206-279-2423
media@adaptivebiotech.com
FAQ
When is Adaptive Biotechnologies (ADPT) participating in the Morgan Stanley Healthcare Conference?
Where can I watch the webcast of Adaptive Biotechnologies' (ADPT) presentation at the Morgan Stanley conference?
What is the focus of Adaptive Biotechnologies (ADPT) as a company?
Where is the Morgan Stanley 22nd Annual Global Healthcare Conference being held?
